JP2014506785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506785A5 JP2014506785A5 JP2013552568A JP2013552568A JP2014506785A5 JP 2014506785 A5 JP2014506785 A5 JP 2014506785A5 JP 2013552568 A JP2013552568 A JP 2013552568A JP 2013552568 A JP2013552568 A JP 2013552568A JP 2014506785 A5 JP2014506785 A5 JP 2014506785A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- mva
- vaccinia virus
- gene cassette
- recombinant vaccinia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438024P | 2011-01-31 | 2011-01-31 | |
| US61/438,024 | 2011-01-31 | ||
| PCT/US2012/023085 WO2012106231A2 (en) | 2011-01-31 | 2012-01-30 | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017126499A Division JP6461244B2 (ja) | 2011-01-31 | 2017-06-28 | インフルエンザａウイルスに対するヘテロサブタイプ免疫応答を誘導するための組換えウイルスベクターおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506785A JP2014506785A (ja) | 2014-03-20 |
| JP2014506785A5 true JP2014506785A5 (enExample) | 2015-03-19 |
| JP6169494B2 JP6169494B2 (ja) | 2017-07-26 |
Family
ID=45561167
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013552568A Active JP6169494B2 (ja) | 2011-01-31 | 2012-01-30 | インフルエンザａウイルスに対するヘテロサブタイプ免疫応答を誘導するための組換えウイルスベクターおよび方法 |
| JP2017126499A Active JP6461244B2 (ja) | 2011-01-31 | 2017-06-28 | インフルエンザａウイルスに対するヘテロサブタイプ免疫応答を誘導するための組換えウイルスベクターおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017126499A Active JP6461244B2 (ja) | 2011-01-31 | 2017-06-28 | インフルエンザａウイルスに対するヘテロサブタイプ免疫応答を誘導するための組換えウイルスベクターおよび方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9463237B2 (enExample) |
| EP (1) | EP2670430B1 (enExample) |
| JP (2) | JP6169494B2 (enExample) |
| CN (1) | CN103458922B (enExample) |
| AU (2) | AU2012212463B2 (enExample) |
| WO (1) | WO2012106231A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012212463B2 (en) * | 2011-01-31 | 2016-07-07 | Nanotherapeutics, Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses |
| US10434166B2 (en) * | 2013-03-15 | 2019-10-08 | University Of Maryland, College Park | Methods and compositions for in vivo immune stimulation and antigen production |
| WO2015006384A1 (en) * | 2013-07-09 | 2015-01-15 | Texas Tech University System | Universal influenza vaccine |
| AU2016342048B2 (en) * | 2015-10-22 | 2022-09-08 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| CA3011014A1 (en) | 2016-01-08 | 2017-07-13 | Geovax, Inc. | Compositions and methods for generating an immune response to a tumor associated antigen |
| US10370416B2 (en) * | 2016-03-01 | 2019-08-06 | Texas Tech University System | Dual purpose universal influenza vaccine confers protective immunity against anthrax |
| EP3464327A1 (en) | 2016-06-03 | 2019-04-10 | Sanofi Pasteur Inc. | Modification of engineered influenza hemagglutinin polypeptides |
| CN107841513B (zh) * | 2016-09-18 | 2023-04-14 | 中国科学院上海巴斯德研究所 | 基于M2e表位的广谱型流感疫苗 |
| CN110167587A (zh) | 2016-11-11 | 2019-08-23 | 摩登纳特斯有限公司 | 流感疫苗 |
| US11311612B2 (en) | 2017-09-19 | 2022-04-26 | Geovax, Inc. | Compositions and methods for generating an immune response to treat or prevent malaria |
| US11576962B2 (en) | 2017-12-21 | 2023-02-14 | Green Biomed, Inc. | Cross-immunizing antigen vaccine and method for preparation thereof |
| CN109096376A (zh) * | 2018-09-20 | 2018-12-28 | 扬州大学 | 流感病毒ha多肽、klh偶联多肽及多克隆抗体的制备方法 |
| CN113004422B (zh) * | 2021-03-04 | 2023-01-20 | 辽宁成大生物股份有限公司 | 一种融合蛋白、含其的疫苗及其应用 |
| WO2023019274A1 (en) * | 2021-08-13 | 2023-02-16 | Purdue Research Foundation | Methods and compositions for vaccination against heterosubtypic influenza viruses using an adenoviral vector leading to enhanced t cell response through autophagy |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045313B1 (en) | 1982-11-30 | 2006-05-16 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant vaccinia virus containing a chimeric gene having foreign DNA flanked by vaccinia regulatory DNA |
| AT393277B (de) | 1990-01-04 | 1991-09-25 | Immuno Ag | Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen |
| KR20140029551A (ko) * | 2006-02-02 | 2014-03-10 | 글로브이뮨 | 면역 반응 유도를 위한 효모-기반 백신 |
| EP1820511A1 (en) * | 2006-02-20 | 2007-08-22 | Prolmmune Limited | MHC binding peptides and their uses |
| WO2008087563A2 (en) * | 2006-12-29 | 2008-07-24 | Institut Pasteur Of Shanghai | Lentivirus pseudotyped with influenza hemagglutinin and methods of use |
| WO2008118487A2 (en) * | 2007-03-26 | 2008-10-02 | University Of Massachusetts Medical School | Compositions and methods for incresing immunogenicity of glycoprotein vaccines |
| US20110177122A1 (en) * | 2008-09-26 | 2011-07-21 | The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services | Dna prime/activated vaccine boost immunization to influenza virus |
| US7998488B2 (en) | 2008-11-14 | 2011-08-16 | Baxter International Inc. | Vaccine formulations and uses thereof |
| JP2012521786A (ja) * | 2009-03-30 | 2012-09-20 | モウント シナイ スクール オフ メディシネ | インフルエンザウイルスワクチン及びその使用 |
| AU2010250780A1 (en) | 2009-05-18 | 2012-01-12 | Panacea Biotec Ltd | Universal influenza vaccine based on recombinant modified vaccinia Ankara virus (MVA) |
| AU2012212463B2 (en) | 2011-01-31 | 2016-07-07 | Nanotherapeutics, Inc. | Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses |
-
2012
- 2012-01-30 AU AU2012212463A patent/AU2012212463B2/en active Active
- 2012-01-30 EP EP12702162.4A patent/EP2670430B1/en active Active
- 2012-01-30 WO PCT/US2012/023085 patent/WO2012106231A2/en not_active Ceased
- 2012-01-30 CN CN201280015880.9A patent/CN103458922B/zh active Active
- 2012-01-30 US US13/982,524 patent/US9463237B2/en active Active
- 2012-01-30 JP JP2013552568A patent/JP6169494B2/ja active Active
-
2016
- 2016-09-30 AU AU2016235002A patent/AU2016235002B2/en active Active
- 2016-10-07 US US15/289,106 patent/US10329583B2/en active Active
-
2017
- 2017-06-28 JP JP2017126499A patent/JP6461244B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Watanabe et al. | Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes | |
| Steel et al. | Influenza virus vaccine based on the conserved hemagglutinin stalk domain | |
| Fan et al. | Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice | |
| Cotter et al. | A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity | |
| Steinhauer et al. | Genetics of influenza viruses | |
| CA3014435C (en) | Improved influenza b virus replication for vaccine development | |
| Paterson et al. | Emerging roles for the influenza A virus nuclear export protein (NEP) | |
| Szewczyk et al. | Introduction to molecular biology of influenza a viruses. | |
| EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
| JP2015119730A5 (enExample) | ||
| Tripp et al. | Virus-vectored influenza virus vaccines | |
| Isakova-Sivak et al. | Influenza vaccine: Progress in a vaccine that elicits a broad immune response | |
| CN103458922B (zh) | 诱导对甲型流感病毒的异源亚型免疫反应的重组病毒载体和方法 | |
| Kim et al. | Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice | |
| Martín-Benito et al. | Influenza virus transcription and replication | |
| Trucchi et al. | Universal influenza virus vaccines: what needs to happen next? | |
| Song et al. | Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production | |
| DeHaven et al. | The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins | |
| JP2014516530A5 (enExample) | ||
| CN104592367A (zh) | 流感病毒np蛋白突变体及其编码基因与应用 | |
| de Wit et al. | Evidence for specific packaging of the influenza A virus genome from conditionally defective virus particles lacking a polymerase gene | |
| Su et al. | Emergence and pandemic potential of avian influenza a (H7N9) virus | |
| RU2020125098A (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита | |
| Lee et al. | Cell culture-based influenza vaccines as alternatives to egg-based vaccines | |
| Plant et al. | Chimeric neuraminidase and mutant PB1 gene constellation improves growth and yield of H5N1 vaccine candidate virus |